Transcelerate Biopharma Inc.
Fiscal year ending 2021. Filed on May 13, 2022.
300 Conshohocken State Road 420
West Conshohocken, Pennsylvania 19428
Transcelerate Biopharma Inc. (EIN: 46-0886344) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2021 IRS Form 990 filing, Transcelerate Biopharma Inc., a 501(c)(6) business league, reported compensation for 9 out of 26 total employees. Among the employees shown here, the average compensation is $660,145. The highest compensated employee at Transcelerate Biopharma Inc. is Dalvir Gill with fiscal year 2021 compensation of $2,010,163.
Revenue, expenses, and employee compensation
Revenue
Expenses
Employee compensation
Reported Compensated Employees
Non-Employee Board Members
Mission Statement
THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.
Revisions to this organization profile
Get an email when new compensation information is released for Transcelerate Biopharma Inc.
Be the first to know when new IRS Form 990 data is published for this organization.